Daniel M. Lane

Oklahoma Medical Research Foundation

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Donald J. Fernbach

Baylor College of Medicine

Walter J. McConathy

University of North Texas

Wataru W. Sutow

Nationwide Children's Hospital

Teresa J. Vietti

Washington University Medical Center

Derrick Lonsdale

Cleveland Clinic

L.O. Laughlin

The Ohio State University

Kenneth A. Starling

West Virginia University

Margaret P. Sullivan

Scripps Institution of Oceanography

Milton H. Donaldson

Cooper University Hospital

D. H. Berry

University of Arkansas for Medical Sciences

Cooperative Institutions

SWOG Cancer Research Network

Oklahoma Medical Research Foundation

Anderson Hospital

Washington University Medical Center

University of Oklahoma

George Washington University

University of Southern California

The University of Texas System

Baylor College of Medicine

Cleveland Clinic

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Competence of Child Health Associates

Archives of Pediatrics and Adolescent Medicine (1973)

Daniel M. Lane

To the Editor.—The recent article by Machotka et al in the February 1973 issue of theJournal(125:199-203) contains some serious errors which should have altered the authors' conclusions about the education of Child Health Associates. The authors evaluated the knowledge of the three groups of students with tests that were not uniform. The examination on basic sciences was a specific basic science test designed to cover material in the Child Health Associates' curriculum. The examination on clinical pediatrics was with a departmental examination developed by members of the Pediatrics Department. Neither of these tests would be satisfactory for establishing any of the groups' competence in either area. A different set of conclusions would be more appropriate. First, junior medical students do not adequately retain basic medical science information, nor do they learn very much about clinical pediatrics during their rotation on pediatrics. Second, any group of reasonably intelligent

10.1001/archpedi.1973.02110190355023

Cite

Citations (7)

Long-term results of reinforcement therapy in children with acute leukemia

Cancer (1975)

Donald J. Fernbach Stephen L. George Wataru W. Sutow Abdelsalam H. Ragab Daniel M. Lane

A total of 180 children with acute leukemia was randomized to one of two induction regimens: vincristine plus prednisone, or 6-mercaptopurine plus prednisone. Of 170 patients evaluable for induction therapy, a hematologic remission was achieved in 83% (72/87) on vincristine plus prednisone, and in 93% (77/83) on 6-mercaptopurine plus prednisone. When hematologic remission was achieved, patients were randomized to one of three maintenance schedules: 6-mercaptopurine alone, 6-mercaptopurine plus prednisone for 4 weeks every 3 months, or 6-mercaptopurine plus prednisone plus vincristine for 4 weeks every 3 months. The durations of hematologic remission were compared from the achievement of hematologic remission to bone marrow relapse. The survival data were presented as an overview of the effect of this initial therapy on duration of survival. There was no statistical difference between the two induction regimens. The most important finding in the comparison of the three maintenance schedules was that reinforcement of 6-mercaptopurine maintenance therapy with either prednisone or prednisone plus vincristine resulted in significantly longer durations of remission. Vincristine added to prednisone for reinforcement after induction of remission by vincristine plus prednisone did not increase the duration of hematologic remission or survival over prednisone reinforcement alone.

Mercaptopurine

Maintenance therapy

10.1002/1097-0142(197511)36:5<1552::aid-cncr2820360503>3.0.co;2-3

Cite

Citations (23)

Combination of vincristine and prednisonein therapy of acute leukemia in children

The Journal of Pediatrics (1968)

Wataru W. Sutow Teresa J. Vietti Donald J. Fernbach Daniel M. Lane Milton H. Donaldson

10.1016/s0022-3476(68)80125-8

Cite

Citations (8)

Clinical Study of Daunomycin and Prednisone for Induction of Remission in Children with Advanced Leukemia

New England Journal of Medicine (1969)

Charlene P. Holton Teresa J. Vietti Audrey H. Nora Milton H. Donaldson W. J. Stuckey

Sixty-seven children with acute leukemia and with one or more previous relapses were treated with Daunomycin and prednisone to determine the effectiveness of this combination for inducing clinical and hematologic remissions. Sixty had acute lymphocytic, and seven acute myelocytic leukemia. Of the former, 39 attained complete, and 10 partial, bone-marrow remission. Of the latter, one had complete, and one partial remission. Median time to onset of remission marrow in the 51 children was 27 days. Maintenance of remission by Daunomycin was not studied. Limiting toxicity included leukopenia, thrombocytopenia, oral ulcerations, Cushingoid appearance and chemical cellulitis at the injection site. Daunomycin and prednisone are a highly effective drug combination for induction of remissions in children with leukemia refractory to conventional antileukemic drugs.

Refractory (planetary science)

Leukopenia

Acute lymphocytic leukemia

10.1056/nejm196901232800401

Cite

Citations (35)

Ovarian leukemia detected by pelvic sonography. A case report

Cancer (1986)

Daniel M. Lane Robyn L. Birdwell

Asymmetric enlargement of the right adnexa in a prepubertal, asymptomatic, 7-year-old girl with acute lymphocytic leukemia (ALL) was detected by pelvic sonography as part of examinations after the discontinuation of therapy. The case is the first where asymptomatic ovarian relapse has been detected prospectively by sonography. The technique should be considered for the follow-up female patients with ALL in remission, although more extensive studies are needed to establish its effectiveness.

Discontinuation

Girl

Transvaginal sonography

10.1002/1097-0142(19861115)58:10<2338::aid-cncr2820581030>3.0.co;2-p

Cite

Citations (12)

Antenatal formula advertising.

PubMed (1995)

Daniel M. Lane

The criticism of antenatal formula advertising by Howard et al1 regrettably reflects how ignorant many pediatricians are about breast-feeding in the community setting. Having been involved in infant nutrition studies on a face-to-face basis for more than 10 years,2 our experience indicates that formula advertising plays an insignificant role in reducing the frequency of breast-feeding among new mothers. Most information about infant nutrition is provided to American mothers through hospitals9 prenatal classes run by Departments of Obstetrics.

Source

Cite

Citations (2)

Chronic myelocytic leukemia

The Journal of Pediatrics (1968)

Daniel M. Lane

Myelocytic leukemia

10.1016/s0022-3476(68)80098-8

Cite

Citations (1)

Another indication for low-density lipoprotein apheresis

The American Journal of Cardiology (1995)